Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

12.88p
   
  • Change Today:
      0.13p
  • 52 Week High: 39.50
  • 52 Week Low: 12.25
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 1,559,148
  • Market Cap: £53.11m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -80.5% -73.3%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.7 2.3
Pr/Book 0.9  
Latest F'cast
Revenue 13.2% 1.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 30.80 (24.50) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31.23 (22.89) (5.96)p n/a n/a n/a n/a 0.0%
31-Dec-25 16.12 (9.10) (3.94)p n/a n/a n/a n/a 0.0%
31-Dec-26 22.00 (12.03) (1.88)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Holding(s) in Company 31-Mar-2025 12:17 RNS
Grant of Options 26-Mar-2025 07:00 RNS
Appointment of Nominated Adviser and sole Broker 06-Mar-2025 07:00 RNS

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 12.88p
Change Today 0.13p
% Change 0.98 %
52 Week High 39.50
52 Week Low 12.25
Volume 1,559,148
Shares Issued 412.47m
Market Cap £53.11m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.58% above the market average26.58% above the market average26.58% above the market average26.58% above the market average26.58% above the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
Price Trend
82.53% below the market average82.53% below the market average82.53% below the market average82.53% below the market average82.53% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average
Income Not Available
Growth
26.40% above the market average26.40% above the market average26.40% above the market average26.40% above the market average26.40% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
13:49 49 @ 13.00p
13:36 5 @ 13.00p
12:59 35,000 @ 12.78p
12:41 178 @ 13.25p
12:41 113 @ 13.25p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page